Evidence map›Paper›PMID 33352858›Full record

ReviewMolecules (Basel, Switzerland)2020

Bioorthogonal Reactions in Activity-Based Protein Profiling.

Steven H L Verhelst, Kimberly M Bonger, Lianne I Willems

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Activity-based protein profiling: A graphical review.Current research in pharmacology and drug discovery · 2023
    Review
  9. Article
  10. Article
  11. Detection of Bacterial α-l-Fucosidases with anMolecules (Basel, Switzerland) · 2022
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Steven H L VerhelstLaboratory of Chemical Biology, Department of Cellular and Molecular Medicine, KU Leuven, Herestr. 49, Box 802, 3000 Leuven, Belgium.ORCID 0000-0002-7400-1319
Kimberly M BongerInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Lianne I WillemsYork Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, UK.ORCID 0000-0001-5411-1329

Funding

Bundesministerium für Bildung und Forschung -Fonds Wetenschappelijk Onderzoek G0D7118NFonds Wetenschappelijk Onderzoek G0D8617NFonds Wetenschappelijk Onderzoek G0E3617NH2020 European Research Council 802940H2020 European Research Council 851448KU Leuven internal funds C3/20/035Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen -NWO NWO-024.002.009Radboud university internal funds -Regierende Bürgermeister von Berlin-inkl. Wissenschaft und Forschung -
6 · The paper itself

Abstract

Activity-based protein profiling (ABPP) is a powerful technique to label and detect active enzyme species within cell lysates, cells, or whole animals. In the last two decades, a wide variety of applications and experimental read-out techniques have been pursued in order to increase our understanding of physiological and pathological processes, to identify novel drug targets, to evaluate selectivity of drugs, and to image probe targets in cells. Bioorthogonal chemistry has substantially contributed to the field of ABPP, as it allows the introduction of tags, which may be bulky or have unfavorable physicochemical properties, at a late stage in the experiment. In this review, we give an overview of the bioorthogonal reactions that have been implemented in ABPP, provide examples of applications of bioorthogonal chemistry in ABPP, and share some thoughts on future directions.

Indexed as

AnimalsEnzymesFluorescent DyesHumansMolecular StructureEnzymesFluorescent Dyesactivity-based probesactivity-based protein profilingbioorthogonal chemistrychemoselective ligationclick chemistrycovalent inhibitorsenzyme probestarget identification

Identifiers

PMID33352858
PMCPMC7765892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.